05:08 PM EST, 12/11/2024 (MT Newswires) -- BriaCell Therapeutics ( BCTX ) said late Wednesday it plans to start an underwritten public offering of common shares and warrants.

Net proceeds from the offering will be used for working capital, general corporate purposes and advancing business objectives, according to the company.

Shares of the company fell nearly 23% in after-hours activity.